# POTASSIUM CHLORIDE
> **ANDA214108** · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2022-03-24
## Drug
- **FDA Application Number:** ANDA214108
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** POTASSIUM CHLORIDE
- **Generic name:** POTASSIUM CHLORIDE
- **Active ingredients:** POTASSIUM CHLORIDE
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RUBICON RESEARCH
- **Manufacturer:** Northstar Rx LLC
- **First approval:** 2022-03-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214108)
---
*AI Analytics · CC0 1.0*